It was announced on November 20th, 2017 that the European Medicines Agency (EMA) will relocate to Amsterdam. This agency plays a crucial role in the development and authorization of orphan medicines in Europe. Orphan medicines are medicinal products intended for the diagnosis, prevention or treatment of rare diseases. Wishing them all the best in their new home!
Read the official press release here